mTOR and cancer: many loops in one pathway
Top Cited Papers
Open Access
- 27 November 2009
- journal article
- review article
- Published by Elsevier in Current Opinion in Cell Biology
- Vol. 22 (2) , 169-176
- https://doi.org/10.1016/j.ceb.2009.10.007
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1Molecular and Cellular Biology, 2009
- Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signalingGenes & Development, 2003
- GβL, a Positive Regulator of the Rapamycin-Sensitive Pathway Required for the Nutrient-Sensitive Interaction between Raptor and mTORMolecular Cell, 2003
- PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanismsPublished by Elsevier ,2003
- Two TOR Complexes, Only One of which Is Rapamycin Sensitive, Have Distinct Roles in Cell Growth ControlMolecular Cell, 2002
- Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt PathwayPublished by Elsevier ,2002
- Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR ActionCell, 2002
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002
- Role of mTOR in the degradation of IRS‐1: Regulation of PP2A activityJournal of Cellular Biochemistry, 2002
- A Rapamycin-Sensitive Pathway Down-Regulates Insulin Signaling via Phosphorylation and Proteasomal Degradation of Insulin Receptor Substrate-1Molecular Endocrinology, 2000